Beckman Coulter
Beckman Coulter announced the availability of SARS-CoV-2 IgG II Assay, a semi-quantitative COVID-19 serology tool which helps clinicians can establish a baseline to evaluate an individual’s immune status based on the numerical value and assess relative changes in an individual’s response to the SARS-CoV-2 virus over time.
Rankings by
National Ranking166th
in United States Regional Ranking179th
in North America and Caribbean Global Ranking444th
worldwide